PKSAX
Price
$54.47
Change
-$0.47 (-0.86%)
Updated
Sep 20 closing price
RPTIX
Price
$109.40
Change
-$0.77 (-0.70%)
Updated
Sep 20 closing price
Ad is loading...

PKSAX vs RPTIX

Header iconPKSAX vs RPTIX Comparison
Open Charts PKSAX vs RPTIXBanner chart's image
Virtus KAR Small-Cap Core A
Price$54.47
Change-$0.47 (-0.86%)
VolumeN/A
CapitalizationN/A
T. Rowe Price Mid-Cap Growth I
Price$109.40
Change-$0.77 (-0.70%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
PKSAX vs RPTIX Comparison Chart
Loading...
VS
PKSAX vs. RPTIX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PKSAX is a Buy and RPTIX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RPTIX has more cash in the bank: 31.4B vs. PKSAX (2.34B). PKSAX pays higher dividends than RPTIX: PKSAX (0.40) vs RPTIX (0.18). PKSAX was incepted earlier than RPTIX: PKSAX (22 years) vs RPTIX (9 years). RPTIX is a more actively managed with annual turnover of: 21.70 vs. PKSAX (10.00). PKSAX has a lower initial minimum investment than RPTIX: PKSAX (2500) vs RPTIX (500000). PKSAX annual gain was more profitable for investors over the last year : 25.70 vs. RPTIX (14.81). PKSAX return over 5 years is better than : 41.53 vs. RPTIX (15.09).
PKSAXRPTIXPKSAX / RPTIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence22 years9 years-
Gain YTD13.8829.127152%
Front LoadN/AN/A-
Min. Initial Investment25005000001%
Min. Initial Investment IRAN/AN/A-
Net Assets2.34B31.4B7%
Annual Yield % from dividends0.400.18219%
Returns for 1 year25.7014.81173%
Returns for 3 years15.93-13.57-117%
Returns for 5 years41.5315.09275%
Returns for 10 years132.20N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLH246.88-0.54
-0.22%
Clean Harbors
TOI0.29N/A
-0.58%
Oncology Institute (The)
CINT6.59-0.04
-0.60%
CI&T
CSTM16.22-0.54
-3.22%
Constellium SE
KTTA4.43-0.37
-7.71%
Pasithea Therapeutics Corp